Phenothiazines and breast cancer
Journal of the National Medical Association
|August 1, 1984
Summary
This study found no significant difference in breast cancer incidence between patients who received phenothiazines and those who did not. The findings suggest phenothiazine use is not associated with increased breast cancer risk.
Area of Science:
- Psychiatry
- Oncology
- Epidemiology
Background:
- Phenothiazines are antipsychotic medications used in psychiatric treatment.
- Concerns exist regarding potential links between medication use and cancer risk.
- Understanding drug-cancer associations is crucial for patient safety.
Purpose of the Study:
- To investigate the incidence of breast cancer in patients treated with phenothiazines.
- To compare breast cancer rates in phenothiazine users versus non-users.
- To assess the association between phenothiazine use and breast cancer development.
Main Methods:
- Retrospective study design.
- Involved 93 patients with breast cancer who received phenothiazines and a control group of 28 patients who did not.
- Data collected over a 21-year period at a psychiatric hospital.
Main Results:
- No statistically significant difference in breast cancer incidence was observed between the phenothiazine group and the control group.
- The incidence rate in the study population (1.85/1,000) was comparable to the general population (2/1,000).
- Phenothiazine use did not appear to elevate breast cancer risk.
Conclusions:
- Phenothiazine treatment is not associated with an increased risk of breast cancer.
- This finding supports the continued use of phenothiazines in psychiatric care when indicated.
- Further research may explore long-term effects and specific drug subtypes.
More Related Videos
Related Concept Videos
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...


